Dan Spiegelman

Dan Spiegelman

Director/Board Member at KYVERNA THERAPEUTICS, INC.

Net worth: 749 191 $ as of 30/05/2024

65 year
Health Technology
Consumer Services
Commercial Services

Dan Spiegelman active positions

CompaniesPositionStartEnd
MYRIAD GENETICS, INC. Director/Board Member 26/05/2020 -
Independent Dir/Board Member 26/05/2020 -
SPRUCE BIOSCIENCES, INC. Director/Board Member 08/09/2020 -
Independent Dir/Board Member 08/09/2020 -
JIYA ACQUISITION CORP. Director/Board Member 17/11/2020 -
Independent Dir/Board Member 17/11/2020 -
KYVERNA THERAPEUTICS, INC. Director/Board Member 31/03/2021 -
Independent Dir/Board Member 31/03/2021 -
Recardia Therapeutics, Inc. President 30/06/2020 -
Director/Board Member 30/09/2020 -
Director/Board Member 14/05/2019 -
Chairman - -
Private Equity Investor - -

Career history of Dan Spiegelman

Former positions of Dan Spiegelman

CompaniesPositionStartEnd
OPTHEA LIMITED Director/Board Member 09/09/2020 03/04/2024
Independent Dir/Board Member 09/09/2020 03/04/2024
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ - ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -
░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░ -

Training of Dan Spiegelman

Stanford University Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Statistics

International

United States 24
Australia 2

Operational

Director/Board Member 15
Independent Dir/Board Member 10
Director of Finance/CFO 3

Sectoral

Health Technology 16
Consumer Services 3
Commercial Services 3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies9
BIOMARIN PHARMACEUTICAL INC.

Health Technology

CYCLACEL PHARMACEUTICALS, INC.

Health Technology

OMEROS CORPORATION

Health Technology

ANTHERA PHARMACEUTICALS, INC.

Health Technology

AFFYMAX, INC.

Health Technology

MYRIAD GENETICS, INC.

Health Technology

SPRUCE BIOSCIENCES, INC.

Health Technology

OPTHEA LIMITED

Health Technology

KYVERNA THERAPEUTICS, INC.

Health Technology

Private companies13

Health Technology

Health Technology

Health Services

Health Technology

Xcyte Therapies, Inc.

Health Technology

Filtini, Inc.

Commercial Services

Health Technology

Health Technology

Finance

Commercial Services

Recardia Therapeutics, Inc.

Finance

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW